Search research articles
Contact Us
Filters
Showing results (341-350 of 513) with videos related to
Page
of 52
Sort By:
European Journal of Heart Failure
|
June 12, 2003
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme
J McMurray, J Ostergren, M Pfeffer, et al.
Journal of Hypertension
|
April 7, 2007
Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system
, F Turnbull, B Neal, et al.
Journal of Cardiac Failure
|
September 25, 1999
Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators
K Swedberg, M Pfeffer, C Granger, et al.
The Journal of Biological Chemistry
|
February 15, 1991
Phosphorylation of the proto-oncogene product eukaryotic initiation factor 4E is a common cellular response to tumor necrosis factor
M W Marino, L J Feld, E A Jaffe, et al.
British Journal of Cancer
|
August 14, 2014
The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?
P Blumenfeld, R M Pfeffer, Z Symon, et al.
The Journal of Biological Chemistry
|
August 2, 2013
Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway
Jo Meagan Garner, Meiyun Fan, Chuan He Yang, et al.
Endocrinology
|
March 30, 2026
Role of JAK-STAT Signaling Pathway in Hormonal Cancer Therapeutic Resistance and Lineage Plasticity
Wendy Effah, Marjana Khalil, Sanskrita Sukla, et al.
The Journal of Biological Chemistry
|
April 25, 1997
The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action
L M Pfeffer, L Basu, S R Pfeffer, et al.
Journal of Cellular and Molecular Medicine
|
July 16, 2022
STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20
Ricardo J Antonia, Eveliina Karelehto, Kan Toriguchi, et al.
Nature
|
September 15, 1999
NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase
O N Ozes, L D Mayo, J A Gustin, et al.
Page
of 52
Search research articles
Search
Showing results (341-350 of 513) with videos related to
Sort By:
Page
of 52
European Journal of Heart Failure
|
June 12, 2003
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme
J McMurray, J Ostergren, M Pfeffer, et al.
Journal of Hypertension
|
April 7, 2007
Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system
, F Turnbull, B Neal, et al.
Journal of Cardiac Failure
|
September 25, 1999
Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators
K Swedberg, M Pfeffer, C Granger, et al.
The Journal of Biological Chemistry
|
February 15, 1991
Phosphorylation of the proto-oncogene product eukaryotic initiation factor 4E is a common cellular response to tumor necrosis factor
M W Marino, L J Feld, E A Jaffe, et al.
British Journal of Cancer
|
August 14, 2014
The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?
P Blumenfeld, R M Pfeffer, Z Symon, et al.
The Journal of Biological Chemistry
|
August 2, 2013
Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway
Jo Meagan Garner, Meiyun Fan, Chuan He Yang, et al.
Endocrinology
|
March 30, 2026
Role of JAK-STAT Signaling Pathway in Hormonal Cancer Therapeutic Resistance and Lineage Plasticity
Wendy Effah, Marjana Khalil, Sanskrita Sukla, et al.
The Journal of Biological Chemistry
|
April 25, 1997
The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action
L M Pfeffer, L Basu, S R Pfeffer, et al.
Journal of Cellular and Molecular Medicine
|
July 16, 2022
STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20
Ricardo J Antonia, Eveliina Karelehto, Kan Toriguchi, et al.
Nature
|
September 15, 1999
NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase
O N Ozes, L D Mayo, J A Gustin, et al.
Page
of 52